TBPH Competitors & Alternatives
Compare Theravance Biopharma Inc with similar stocks in the same industry
Biotechnology
TBPH
Main Stock$16.74
Tradestie Score
59
Market Cap
$726.21M
P/E Ratio
8.1
Revenue Growth
1.4%
Analyst Upside
+2.7%
Top Competitors
218 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABUS
Arbutus Biopharma Corporation Common Stock
|
$4.20
|
$879.90M | - | 54 | Compare |
|
PHAT
Phathom Pharmaceuticals, Inc. Common Stock
|
$11.20
|
$871.90M | - | 55 | Compare |
|
TSHA
Taysha Gene Therapies, Inc. Common Stock
|
$6.39
|
$867.49M | - | 61 | Compare |
|
FTRE
Fortrea Holdings Inc. Common Stock
|
$11.50
|
$864.42M | - | 62 | Compare |
|
CRMD
CorMedix Inc.
|
$7.59
|
$862.55M | 3.7 | 63 | Compare |
|
EVMN
EVMN
|
$23.80
|
$859.04M | - | 50 | Compare |
|
SEPN
Septerna, Inc. Common Stock
|
$23.76
|
$847.12M | - | 51 | Compare |
|
XNCR
Xencor, Inc.
|
$11.93
|
$843.75M | - | 53 | Compare |
|
GHRS
GH Research PLC Ordinary Shares
|
$20.53
|
$841.74M | - | 59 | Compare |
|
KOD
Kodiak Sciences Inc Common Stock
|
$43.48
|
$832.47M | - | 60 | Compare |
More TBPH Analysis
Data updated: May 01, 2026 | Industry: Biotechnology (SIC 2834)
218 stocks in this industry